Sylvie Freeman

33PUBLICATIONS
168CO-AUTHORS
Stochastic analysis and modellingHaematological tumoursMedical mycologyCancer therapy (excl. chemotherapy and radiation therapy)Medical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (33)

|Aug 14, 2026
Prognostic value of measuring LSC frequency in AML: a systematic review and meta-analysis.

|Jun 25, 2026
Combining Quizartinib with intensive chemotherapy in older patients with newly diagnosed AML: results of the UK NCRI AML18 Trial.

|Dec 15, 2025
2025 update on MRD in acute myeloid leukemia: a consensus document from the ELN-DAVID MRD Working Party.

Jacqueline Cloos, Peter J M Valk, Christian Thiede

|Nov 14, 2025
CPX-351 vs daunorubicin, cytarabine, and gemtuzumab ozogamicin in older adults with non-adverse-risk AML: the NCRI AML18 trial.

Steven Knapper, Laura W Dillon, Malavika Babu

|Sep 30, 2025
Safety and efficacy of combining midostaurin and gemtuzumab ozogamicin with induction chemotherapy in FLT3-mutated AML.

Nigel Russell, Jad Othman, Oliver Cumming

|Aug 06, 2025
Induction chemotherapy and molecular MRD influence outcomes in KMT2A-rearranged AML.

Jad Othman, Nicola Potter, Sylvie D Freeman

Pageof 6

Frequent Collaborators

11 joint publications

Steven Knapper

9 joint publications

Richard Dillon

8 joint publications

Abin Thomas

8 joint publications

Jad Othman